Abstract:Background: The N-linked oligosaccharides of human chorionic gonadotropin become more complicated in cancer. Results: MCA1024 alters its binding affinity against different human chorionic gonadotropin glycoforms. Conclusion: The N-glycosylations at Asn-13 and Asn-30 on the β subunit are crucial to the binding affinity of MCA1024. Significance: The aberrant glycosylation of cancer biomarkers might potentially be monitored by specific antibodies. The glycosylation of human chorionic gonadotropin (hCG) plays an important role in reproductive tumors. Detecting hCG N-glycosylation alteration may significantly improve the diagnostic accuracy and sensitivity of related cancers. However, developing an immunoassay directly against the N-linked oligosaccharides is unlikely because of the heterogeneity and low immunogenicity of carbohydrates. Here, we report a hydrogen/deuterium exchange and MS approach to investigate the effect of N-glycosylation on the binding of antibodies against different hCG glycoforms. Hyperglycosylated hCG was purified from the urine of invasive mole patients, and the structure of its N-linked oligosaccharides was confirmed to be more branched by MS. The binding kinetics of the anti-hCG antibodies MCA329 and MCA1024 against hCG and hyperglycosylated hCG were compared using biolayer interferometry. The binding affinity of MCA1024 changed significantly in response to the alteration of hCG N-linked oligosaccharides. Hydrogen/deuterium exchange-MS reveals that the peptide β65–83 of the hCG β subunit is the epitope for MCA1024. Site-specific N-glycosylation analysis suggests that N-linked oligosaccharides at Asn-13 and Asn-30 on the β subunit affect the binding affinity of MCA1024. These results prove that some antibodies are sensitive to the structural change of N-linked oligosaccharides, whereas others are not affected by N-glycosylation. It is promising to improve glycoprotein biomarker-based cancer diagnostics by developing combined immunoassays that can determine the level of protein and measure the degree of N-glycosylation simultaneously.

Recognition of N-Glycoforms in Human Chorionic Gonadotropin by Monoclonal Antibodies and Their Interaction Motifs

Isomer-specific Biomarker Discovery in Multiple Myeloma with Dual-Derivatized N-glycans.

N-glycosylation of Serum Proteins for the Assessment of Patients with IgD Multiple Myeloma

Robust Glycoproteomics Platform Reveals a Tetra‐Antennary Site‐Specific Glycan Capping with Sialyl‐Lewis Antigen for Early Detection of Gastric Cancer

Disease-Specific Haptoglobin N-Glycosylation in Inflammatory Disorders between Cancers and Benign Diseases of 3 Types of Female Internal Genital Organs

Identification of Mono- and Disulfated N-Acetyl-Lactosaminyl Oligosaccharide Structures As Epitopes Specifically Recognized by Humanized Monoclonal Antibody Hmocc-1 Raised Against Ovarian Cancer

Biomolecular recognition of the glycan neoantigen CA19-9 by distinct antibodies

Comprehensive N-Glycome Profiling of Cells and Tissues for Breast Cancer Diagnosis.

Quantitation of Site-Specific Glycosylation in Manufactured Recombinant Monoclonal Antibody Drugs

Glycomics: Immunoglobulin G<i>N</i>-Glycosylation Associated with Mammary Gland Hyperplasia in Women

Identification and semi-relative quantification of intact glycoforms of human chorionic gonadotropin alpha and beta subunits by nano liquid chromatography-Orbitrap mass spectrometry

Characterization of N-linked intact glycopeptide signatures of plasma IgGs from patients with prostate carcinoma and benign prostatic hyperplasia for diagnosis pre-stratification.

Presentation Mode of Glycans Affect Recognition of Human Serum anti-Neu5Gc IgG Antibodies.

Assessment Of New Biomarkers For Ovarian Carcinoma With Serum N-Glycan Profiling

Revealing the Changes of IgG Subclass-Specific N-glycosylation in Colorectal Cancer Progression by High-Throughput Assay

Site-specific N-glycosylation characterization of micro monoclonal immunoglobulins based on EThcD-sceHCD-MS/MS

Profiling Anti-Neu5Gc IgG in Human Sera with a Sialoglycan Microarray Assay.

Aberrant N-glycolylneuraminic acid in breast MCF-7 cancer cells and cancer stem cells.

Causal link between immunoglobulin G glycosylation and cancer: A potential glycobiomarker for early tumor detection

Cell Surface-Specific N-glycan Profiling in Breast Cancer.

Specific Analysis of Α-2,3-sialylated N-Glycan Linkage Isomers by Microchip Capillary Electrophoresis–Mass Spectrometry